In this week’s article, we meet Alex Khzouz, a first year Global Medical Affairs fellow with BD. Alex attended our Industry Fellowship Day in 2018 as a prospective fellow, and offers his perspective on the event and how it helped him feel more prepared for ASHP. This year’s event will be held on Saturday, October … Continue reading An Inside Look: Industry Fellowship Day
Even though QA is generally associated with a finished product, during the drug development process, there is always ongoing safety oversight at every stage. At Novartis, programs focus on early phase clinical trials, so Kaitlin has a unique perspective on QA as someone who is primarily involved at the beginning of the drug development process. Read more to learn about what inspired her to pursue a fellowship in early phase quality assurance and what she's most proud of from her first year.
Meet Mary Bylo, one of our Novartis CS&I fellows! Learn about what makes the Novartis program unique and how Mary decided to pursue a fellowship.
The MFN receives guidance and assistance from two Alumni Representatives who serve two year terms. For this article, we would like to introduce Melissa Laracy as our newest Alumni Representative. Melissa recently completed a fellowship at Biogen and has accepted a position with them post-Fellowship. In her article this week, Melissa reflects on her involvement as an MFN E-Board member and the value of having a network during her fellowship.
Joining any kind of post-graduate training program comes with many benefits. With the culmination of her fellowship in June, outgoing MFN President, Abimbola Cole asked to write about her experiences from her two year program. Continue reading to learn about her activities as a fellow and member of the MFN community.